MedPath

Assessment Ayurveda Drug Shadbindu Taila as Nasal drop, Trayodashanga Guggulu tab as oral medication and Physio Therapy In The Management Of Cervical Spondylosis and Anti Inflammatory Effect Of Nasya - A Randomized Controlled Clinical Study

Phase 2
Conditions
Health Condition 1: M472- Other spondylosis with radiculopathy
Registration Number
CTRI/2020/06/025538
Lead Sponsor
Institute for Post Graduate Training and Research in Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Diagnosed cases of cervical spondylosis

Participants of age group between 18 to 65 years, belonging to either of the sex

Participants indicated for nasya karma

Willing to sign the consent for study participation.

Exclusion Criteria

Uncontrolled diabetes mellitus, hypertension and other systemic illness

Ankylosing spondylitis, adhesive capsulitis etc

Anemia (hemoglobin % <07.00 mg/dl)

Pregnancy

Participants contraindicated for nasya

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relief in signs and symptoms of cervical spondylosisTimepoint: within 2 years of time
Secondary Outcome Measures
NameTimeMethod
Improvement in quality of life and social well being of participantTimepoint: Within 2years from trial
© Copyright 2025. All Rights Reserved by MedPath